Northwest Biotherapeutics | NWBO - Операционный доход





Операционный доход Изменить Дата
Agenus USD -13.31M 12.58M 2025-03
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Merck USD 6.24B 318M 2025-12
Northwest Biotherapeutics USD -14.8M 2.66M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12